Company Repros Therapeutics Inc
Equities
US76028H2094
Biotechnology & Medical Research
Managers
Managers | Title | Age | Since |
---|---|---|---|
Ambrose Bailey
PSD | President | 60 | 18-01-30 |
Chief Tech/Sci/R&D Officer | 76 | 13-02-04 | |
Kira Schwartz
SEC | Corporate Secretary | - | 18-01-30 |
Stephen Kaufhold
TRE | Treasurer | - | 18-01-30 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 39,667,483 | 39,300,147 ( 99.07 %) | 112,350 ( 0.2832 %) | 99.07 % |
Company contact information
![address Repros Therapeutics Inc](https://cdn.zonebourse.com/static/address/11482.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+21.85% | 46.44B | |
+38.96% | 39.1B | |
-8.05% | 38.76B | |
+29.04% | 31.24B | |
-13.75% | 25.8B | |
+10.65% | 25.9B | |
+38.43% | 13.12B | |
-6.92% | 11.32B | |
-12.29% | 10.68B |